Canada animal vaccine market is estimated to grow at a CAGR of around 7.8% during the forecast period. The major factors contributing to the growth of the market include the increasing adoption of pets among households. As per the Food and Agriculture Organization of the United Nations (FAO), the production of chickens in Canada was 170,442, per 1000 head in 2017 and 170,106, per 1000 head in 2016. This growth in chickens results in the emerging focus on proper health of poultry birds, which in turn, is promoting the growth of the market in Canada.
Moreover, Canadian pet health regulatory norms are such that a person needs to keep a health certificate to carry the pet outside Canada. It ensures compulsory vaccination for the pets. This is expected to further promote the demand for animal vaccines in Canada, thereby promoting the growth of the market in the near future. The growing awareness among people regarding animal health is encouraging the demand for animal vaccines in the country.
Some crucial players in the Canada animal vaccine market include Zoetis, Inc., Elanco, Merck & Co., Inc., Novartis International AG and Vetoquinol SA. To survive in the market, these players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations. This enables the company to increase its competitiveness and attract significant share in the market. For instance, in December 2019, Vétoquinol acquired animal health business assets of VETCOM 1979 INC. The VETCOM 1979 INC. animal health business comprises annual revenue of nearly $1.1 million. This will enable Vétoquinol to reinforce their presence in Canada in the companion animal market.
Research Methodology
The market study of the Canada animal vaccine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.
Secondary Sources Include:
The report is intended for pharmaceuticals companies, veterinary companies, government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation:
The Report covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Canada Animal Vaccine Market by Type
5.1.1. Porcine Vaccines
5.1.2. Poultry Vaccines
5.1.3. Livestock Vaccines
5.1.4. Aquaculture Vaccines
5.1.5. Companion Animal Vaccines
5.1.6. Other Animal Vaccines
5.2. Canada Animal Vaccine Market by Technology
5.2.1. Live Attenuated Vaccine
5.2.2. Killed/Inactive Vaccine
5.2.3. Recombinant Vaccine
5.2.4. Vectored Vaccine
5.2.5. Subunit Vaccine
5.2.6. DNA Vaccine
5.2.7. Chimeric Vaccine
5.2.8. Others
6. Company Profiles
6.1. Bimeda Holdings PLC
6.2. Boehringer Ingelheim International GmbH
6.3. Elanco
6.4. Merck & Co., Inc.
6.5. Neogen Corp.
6.6. Novartis International AG
6.7. VBI Vaccines Inc.
6.8. Vetoquinol SA
6.9. Virbac SA
6.10. Zoetis, Inc.
1. CANADA ANIMAL VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
2. CANADA ANIMAL VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION
1. CANADA ANIMAL VACCINE MARKET SHARE BY TYPE, 2018 VS 2025 (%)
2. CANADA ANIMAL VACCINE MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)